We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
World of Zing is a contemporary food emporium that have curated a range of London's finest food and drinks producers, from bartenders and chefs to street foodies. World of Zing aim to be the place people go to for exciting food and drink needs.
days to go: Expired investment: £186,710
Market Halls (MH) takes unloved public spaces and transforms them into destinations for all-day drinking and dining. MH claims to offer something for everyone, taking visitors seamlessly from breakfast through to late-night snacks. It argues that it has established three venues in Fulham, Victoria and the West End that have attracted crowds in excess of 1.04 million in 2019. MH asserts that it received a Net Promoter Score (NPS) of 62, generated £15 million in revenue in 2020, and has featured in publications such as The Telegraph, The Guardian and Independent. MH also stresses that it has a ‘Best in Class’ retention rate of 80% repeat business. It states it will use the investment to scale up its business with a new identity, new gold-dust venues and an improved customer offering.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £787,240
Prir is a new premium functional soft drink that not only provides a great tasting, healthier way to hydrate but also gives you the valuable nutrition you need to help maintain healthy skin, hair and nails. Prir is currently stocked in over 300 Boots stores nationwide and is also available in the boots meal deal.
days to go: Expired investment: £12,770
Guest are creating the world's best cocktail bar. They aim to do this by offering a new menu from some of the most creative food and cocktail innovators in the world. With the money invested Guest are going to place a deposit on a venue for the bar, refurbish and fit out the venue and then start an international marketing campaign.  
days to go: Expired investment: £107,180
Tap Coffee have been trading for the last 5 years and have been profitable for the last 3. They roast, retail, wholesale and sell their coffee online. Currently Tap Coffee have 3 busy coffee stores located in central London. 
days to go: Expired investment: £86,510
Positivitea is a range of teas based on the chakras. They are already stocked in over 80 locations throughout the UK and Europe including Urban Outfitters and Fenwick. The use of the proceeds raised will go towards expanding the team and getting Positivitea in more retail outlets and being used by more suppliers.
days to go: Expired investment: £103,640
Wantsum Brewery are a brewery based in East Kent with the aim to create more 'hoppy' beers. Wantsum Brewery currently produce 8 regular ales and 10 seasonal and special ales which are sold to pubs and bottle outlets throughout East Kent. 
days to go: Expired investment: £40,150
Specilaing in making a wide variety of award-winning pies and pastry products for the public. Eat Square's 2017 funding round has resulted in their turnover more than doubling in 2018. This growth has led to Eat Square expanding their business and begin to sell franchises to market their goods. Production and capacity have also increased and products that are vegan and gluten-free are being produced. This funding round will see the business sell up to 14 franchises by the end of 2019 to buy their pies.
days to go: Expired investment: £34,019
Wantsum Brewery is a brewery based in East Kent and was created with the aim of creating more hoppy beers. Wantsum Brewery intend to open 2 Wantsum Ale Houses this year with a further 1 Ale House every year for then next 5 years. By doing this they are securing the distribution of their product direct to the customer through their own premises.
days to go: Expired investment: £40,150
Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
days to go: Expired investment: £357,179
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph